Virtual Network's Login.
This educational conference has been approved for 17 CME-CPD credit points
by the European Board for Accreditation in Haematology (EBAH)!
There is only ONE MONTH LEFT to go before #ESHMM2023,
it's time to register!
DO NOT MISS THE OPPORTUNITY:
About the Conference:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
• How I treat smoldering myeloma
• How I treat newly diagnosed multiple myeloma
• From risk stratification to risk-based therapy?
• Should we use MRD testing to determine therapy in multiple myeloma?
• Is there a future role of autologous stem cell transplantation?
• How I treat relapsed multiple myeloma
• The FDA/EMEA and Foundations perspective on multiple myeloma
• Should every patient receive daratumumab in first line?
• You can’t be immune for immune therapy anymore
• Other plasma cell dyscrasias
• The future of multiple myeloma
For more information, click here!
With the support of*:
Major Conference Partners
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
